骨整合植入市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、材料、最終用途、地區及競爭格局分類，2021-2031年）

全球骨整合植入市場預計將從 2025 年的 90.3 億美元成長到 2031 年的 143.6 億美元，複合年成長率為 8.04%。

這些植入被定義為一種假體裝置，它能在天然骨骼和承重假體固定裝置之間建立直接的結構和功能連接，而無需中間軟組織填充。推動這一市場成長的關鍵因素包括全球人口快速老化以及骨關節炎和無牙症等慢性骨病發病率的上升，這些疾病需要長期重組手術。澳洲整形外科協會國家關節重建登記處的一份報告也印證了這種日益成長的臨床需求，該報告指出，到2024年，預計將進行約213萬例髖關節、膝關節和肩關節關節重建手術，凸顯了對骨整合解決方案的巨大需求。

然而，這些先進技術也帶來了潛在的生物學併發症和高成本等重大挑戰。諸如植體周圍植入和骨組織與植入材料整合失敗等臨床問題，可能導致昂貴的修復手術和患者不滿。這些風險要求嚴格的監管合規和長期的密切監測，這可能會阻礙新技術進入市場，並減緩其市場普及速度。

市場促進因素

患者對美觀牙齒修復和美容牙科治療的需求激增，成為市場擴張的主要催化劑，這主要源於他們對自然美觀、持久耐用的牙齒缺失解決方案的日益重視。與活動植入相比，骨整合植入的臨床優勢進一步強化了這一趨勢，植體具有更高的穩定性，並有助於保護顎骨結構。領先的製造商正經歷著顯著的市場成長。例如，士卓曼集團在其2024年2月發布的2023年度報告中指出，其年銷售額達到24億瑞士法郎，這主要得益於其植入業務兩位數的銷售成長。同樣，ZimVie公司在2024年2月發布的2023年第四季及全年財務報告中也強調，其第三方牙科淨銷售額達到4.572億美元。

此外，骨錨式義肢卓越的功能性活動能力和生活品質是其備受青睞的關鍵因素，尤其對於肢體缺失或遭受創傷的患者更是如此。與可能導致皮膚問題和限制活動的傳統套筒式義肢不同，骨整合系統直接固定在骨骼上，提供出色的本體感覺和可靠的機械控制。這項技術變革正推動截肢患者群體迅速接受此類義肢，Integrum AB 於 2024 年 5 月發布的《2023/24 會計年度財務報告》印證了這一點。該公司報告淨銷售額為 1.041 億瑞典克朗，較上年度成長 40.2%，反映出骨錨式活動解決方案在全球範圍內的日益普及。

市場挑戰

由於生物風險和不斷上漲的手術成本的雙重壓力，骨整合植入市場面臨巨大的成長障礙。由於其固有的臨床失敗風險，例如植體周圍植入和骨不連，監管機構對新參與企業制定了嚴格的監管要求。這些要求增加了先進修復解決方案商業化所需的時間和資金，從而有效地減緩了創新步伐。此外，這些器械的高昂費用也限制了其普及，因為醫療系統和保險公司會仔細審查一旦植入失敗，高昂的翻修手術費用是否具有長期的經濟永續性。

大量患者需要持續監測，這加劇了營運方面的挑戰，對醫療資源造成了巨大壓力。正如英國國家關節登記處2025年年度報告所述，僅在2024年，就報告了263,865例髖關節、膝關節、肩關節、肘關節和關節重建關節重建。如此高的手術量凸顯了強制性長期追蹤和監管合規所帶來的巨大後勤和經濟負擔。因此，製造商被迫將大量資源投入上市後監測，而非研發，這直接阻礙了下一代骨整合技術的快速引入和廣泛應用。

市場趨勢

機器人和導航手術系統的應用正在從根本上改變臨床工作流程，顯著提升器械放置的精確度。這些技術利用即時觸覺回饋和術前數位化規劃，確保最佳定位，這對於最大限度地減少組織損傷和提高複雜整形外科和牙科手術的初始穩定性至關重要。隨著臨床醫生尋求減少人為誤差並提高手術一致性，這些自動化平台的應用正在加速。產業數據也印證了這一趨勢，例如Neocis公司於2024年1月發布的題為「牙科機器人領導者獲得2000萬美元資金籌措」的新聞稿，該新聞稿指出，該公司已使用其機器人平台植入超過4萬顆植入，凸顯了自動化手術執行的日益普及。

同時，將3D列印技術應用於患者特異性植入正在重新定義重組標準，使得生產傳統製造技術無法複製的複雜解剖形狀成為可能。積層製造技術有助於建構高度多孔的鈦晶格，模擬鬆質骨結構，從而促進更深層的生物固定，並加速嚴重解剖缺陷患者的骨融合過程。這種向客製化解決方案的轉變正在為產業創造巨大的經濟價值。根據Materials公司於2024年2月發布的“2023年第四季及全年財務業績”，醫療部門營收年增19.5%至1.01376億歐元，反映出市場對客製化骨整合技術的需求日益成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球骨整合植入市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品（人工植牙、髖植入、膝關節移植、脊椎移植、其他）
  • 依材質（陶瓷植入、氧化鋯植入、不銹鋼植入、鈦植入體、金屬植入、其他）
  • 按用途（醫院、門診機構）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美骨整合植入市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲骨整合植入市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區骨整合植入市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲骨整合植入市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美骨整合植入市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球骨整合植入市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Zimmer Biomet
• Straumann
• Nobel Biocare
• Dentsply Sirona
• Stryker
• Integrum
• Osstem
• MIS Implants
• Biomet
• Corin

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Osseointegration Implants Market is projected to expand from USD 9.03 Billion in 2025 to USD 14.36 Billion by 2031, registering a CAGR of 8.04%. These implants are defined as prosthetic devices that create a direct structural and functional connection between living bone and a load-bearing artificial fixture, bypassing the need for intervening soft tissue. The primary drivers fueling this market growth include a rapidly aging global population and the rising incidence of chronic bone disorders, such as osteoarthritis and edentulism, which require long-term reconstructive surgeries. This increasing clinical necessity is highlighted by the Australian Orthopaedic Association National Joint Replacement Registry, which reported a cumulative total of approximately 2.13 million hip, knee, and shoulder replacement procedures in 2024, emphasizing the substantial demand for osseointegrated solutions.

However, the industry faces significant hurdles regarding potential biological complications and the high costs inherent to these advanced procedures. Clinical issues such as peri-implantitis or the failure of the bone to properly fuse with the implant material can result in expensive revisions and patient dissatisfaction. These risks necessitate strict regulatory compliance and rigorous long-term monitoring, which can create barriers to entry for new technologies and slow the rate of widespread market adoption.

Market Driver

The surging demand for aesthetic dental restorations and cosmetic dentistry acts as a major catalyst for market expansion, as patients increasingly prioritize visually natural, long-term solutions for tooth loss. This trend is reinforced by the clinical superiority of osseointegrated implants over removable dentures, which offer enhanced stability and help preserve jawbone structure. Leading manufacturers are observing significant uptake in adoption; for instance, Straumann Group reported full-year revenue of CHF 2.4 billion in its 'Annual Report 2023' released in February 2024, driven by double-digit volume growth in its implantology business. Similarly, ZimVie Inc.'s 'Fourth Quarter and Full Year 2023 Financial Results' from February 2024 highlighted third-party net sales of $457.2 million specifically from its dental segment.

Additionally, the superior functional mobility and quality of life provided by bone-anchored prosthetics serve as a critical driver, particularly for patients dealing with limb loss and trauma. Unlike conventional socket prostheses that can cause skin complications and restrict movement, osseointegrated systems attach directly to the skeleton to enable improved proprioception and reliable mechanical control. This technological shift is fostering rapid acceptance among amputee populations, as evidenced by Integrum AB's 'Year-End Report 2023/24' in May 2024. The company reported net sales of 104.1 million SEK, a 40.2% increase over the previous fiscal year, reflecting the expanding global utilization of these bone-anchored mobility solutions.

Market Challenge

The osseointegration implants market faces a substantial impediment to growth stemming from the combined pressures of biological risks and elevated procedural costs. The inherent potential for clinical failures, such as peri-implantitis or incomplete bone fusion, compels regulatory bodies to mandate stringent surveillance requirements for new market entrants. These obligations increase the time and capital needed to bring advanced prosthetic solutions to commercialization, effectively stalling the pace of innovation. Furthermore, the financial burden of these devices limits accessibility, as healthcare systems and insurers scrutinize the long-term economic viability of funding expensive revisions in cases of implant failure.

This operational challenge is exacerbated by the immense volume of patients requiring continuous monitoring, which places a heavy strain on healthcare resources. As noted in the National Joint Registry's 2025 Annual Report, 263,865 hip, knee, shoulder, elbow, and ankle replacement procedures were submitted during the 2024 calendar year alone. Such a high procedural volume underscores the massive logistical and financial liability associated with mandatory long-term follow-up and regulatory compliance. Consequently, manufacturers must divert significant resources toward post-market surveillance rather than research and development, directly hampering the sector's ability to rapidly introduce and scale next-generation osseointegrated technologies.

Market Trends

The implementation of robotic-assisted and navigational surgical systems is fundamentally altering clinical workflows by enhancing the precision of fixture placement. These technologies utilize real-time haptic guidance and pre-operative digital planning to ensure optimal positioning, which is critical for minimizing tissue trauma and maximizing initial stability in complex orthopedic and dental procedures. The adoption of such automated platforms is accelerating as clinicians seek to reduce human error and improve operative consistency. This uptake is substantiated by industry data; in January 2024, Neocis reported in the press release 'Dental robotics leader Neocis secures $20M in funding' that a cumulative total of more than 40,000 implants have been placed using its robotic-assisted platform, highlighting the growing reliance on automated surgical execution.

Concurrently, the integration of three-dimensional printing for patient-specific implants is redefining reconstruction standards by enabling the fabrication of complex, anatomically matched geometries that traditional manufacturing cannot reproduce. Additive manufacturing facilitates the creation of highly porous titanium lattices that mimic trabecular bone structure, thereby promoting deeper biological fixation and accelerating the fusion process for patients with severe anatomical defects. This shift toward customized solutions is generating substantial economic value within the sector; according to Materialise's 'Fourth Quarter and Full Year 2023 Results' in February 2024, revenue from its Medical segment grew by 19.5% year-over-year to 101,376 kEUR, reflecting the surging demand for tailored osseointegration technologies.

Key Market Players

• Zimmer Biomet
• Straumann
• Nobel Biocare
• Dentsply Sirona
• Stryker
• Integrum
• Osstem
• MIS Implants
• Biomet
• Corin

Report Scope

In this report, the Global Osseointegration Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Osseointegration Implants Market, By Product

• Dental Implants
• Hip Implants
• Knee Implants
• Spinal Implants
• Others

Osseointegration Implants Market, By Material

• Ceramic Implants
• Zirconia Implants
• Stainless Steel Implants
• Titanium Implants
• Metallic Implants
• Others

Osseointegration Implants Market, By End Use

• Hospitals
• Outpatient Facilities

Osseointegration Implants Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Osseointegration Implants Market.

Available Customizations:

Global Osseointegration Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Osseointegration Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dental Implants, Hip Implants, Knee Implants, Spinal Implants, Others)
  • 5.2.2. By Material (Ceramic Implants, Zirconia Implants, Stainless Steel Implants, Titanium Implants, Metallic Implants, Others)
  • 5.2.3. By End Use (Hospitals, Outpatient Facilities)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Osseointegration Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Material
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Osseointegration Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Osseointegration Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Osseointegration Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End Use

7. Europe Osseointegration Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Material
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Osseointegration Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Osseointegration Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Osseointegration Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Osseointegration Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Osseointegration Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End Use

8. Asia Pacific Osseointegration Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Material
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Osseointegration Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Osseointegration Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Osseointegration Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Osseointegration Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Osseointegration Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Osseointegration Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Material
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Osseointegration Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Osseointegration Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Osseointegration Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End Use

10. South America Osseointegration Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Material
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Osseointegration Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Osseointegration Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Osseointegration Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Osseointegration Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zimmer Biomet
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Straumann
• 15.3. Nobel Biocare
• 15.4. Dentsply Sirona
• 15.5. Stryker
• 15.6. Integrum
• 15.7. Osstem
• 15.8. MIS Implants
• 15.9. Biomet
• 15.10. Corin

16. Strategic Recommendations

17. About Us & Disclaimer